Business

NANOBIOTIX to Participate in Investor Conferences in March

PARIS and CAMBRIDGE, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March: TD Cowen's Health Care ConferenceDate: Wednesday, March 4, 2026Location: Boston, MATime of the fireside chat: 11:1

articleNanobiotix SaFebruary 25, 20262/company/nanobiotix-sa-1/news/nanobiotix-to-participate-in-investor-conferences-in-march-1
NANOBIOTIX to Participate in Investor Conferences in March

About this update from Nanobiotix Sa

[{"type":"image","alt":"Nanobiotix S.A.","displaySize":"","headline":null,"caption":"Nanobiotix S.A.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":100,"url":"https://media.zenfs.com/en/globenewswire.com/ae5026f0933e6f98c5e60a809a606998"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/w.WG45QhRIjOjkLYfarG8w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ae5026f0933e6f98c5e60a809a606998","width":300,"height":100}},"lazy":false},{"type":"text","content":"PARIS and CAMBRIDGE, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:","length":385,"tagName":"p"},{"type":"text","content":"TD Cowen's Health Care ConferenceDate: Wednesday, March 4, 2026Location: Boston, MATime of the fireside chat: 11:10am ET / 5:10pm CETPresenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix","length":277,"tagName":"p"},{"type":"text","content":"UBS Biotech Summit Miami Date: Monday, March 9, 2026Location: Miami Beach, FL","length":79,"tagName":"p"},{"type":"text","content":"Jefferies Biotech on the Beach Summit Date: Tuesday, March 10, 2026Location: Miami Beach, FL","length":94,"tagName":"p"},{"type":"text","content":"Leerink's Global Healthcare ConferenceDate: Wednesday, March 11, 2026Location: Miami Beach, FLTime of the fireside chat: 2:20pm EDT / 7:20pm CETPresenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix","length":288,"tagName":"p"},{"type":"text","content":"About NANOBIOTIX","length":16,"tagName":"p"},{"type":"text","content":"Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.","l...

More updates from Nanobiotix Sa

NANOBIOTIXLaurent Levytreatment possibilitiesEuronext Paristherapeutic approachesMiami Beach, FLNASDAQupcoming conferencesBart van RhijnChief Executive Officerbiotechnology companyfireside chat